FR2944446B1 - Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant - Google Patents

Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant

Info

Publication number
FR2944446B1
FR2944446B1 FR0901825A FR0901825A FR2944446B1 FR 2944446 B1 FR2944446 B1 FR 2944446B1 FR 0901825 A FR0901825 A FR 0901825A FR 0901825 A FR0901825 A FR 0901825A FR 2944446 B1 FR2944446 B1 FR 2944446B1
Authority
FR
France
Prior art keywords
soothing
cosmetic
pharmaceutical composition
peptide hydrolyzate
hydrolyzate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0901825A
Other languages
English (en)
Other versions
FR2944446A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Jean Marie Botto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISP Investments LLC
Original Assignee
ISP Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISP Investments LLC filed Critical ISP Investments LLC
Priority to FR0901825A priority Critical patent/FR2944446B1/fr
Publication of FR2944446A1 publication Critical patent/FR2944446A1/fr
Application granted granted Critical
Publication of FR2944446B1 publication Critical patent/FR2944446B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0901825A 2009-04-15 2009-04-15 Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant Expired - Fee Related FR2944446B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0901825A FR2944446B1 (fr) 2009-04-15 2009-04-15 Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0901825A FR2944446B1 (fr) 2009-04-15 2009-04-15 Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant

Publications (2)

Publication Number Publication Date
FR2944446A1 FR2944446A1 (fr) 2010-10-22
FR2944446B1 true FR2944446B1 (fr) 2013-08-16

Family

ID=40974605

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0901825A Expired - Fee Related FR2944446B1 (fr) 2009-04-15 2009-04-15 Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant

Country Status (1)

Country Link
FR (1) FR2944446B1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101384744B1 (ko) * 2011-05-23 2014-04-14 주식회사 인코스팜 보습능이 우수한 펩타이드 유도체 및 이의 용도
FR2990132B1 (fr) * 2012-05-04 2014-06-06 Cocagne & Cie Extrait proteique de graine d'isatis tinctoria et compositions cosmetiques, dermatologiques ou pharmaceutiques le comprenant
WO2016005243A1 (fr) * 2014-07-08 2016-01-14 Henkel Ag & Co. Kgaa Agents cosmétiques anti-transpirants avec des protéines spéciales provenant de légumineuses de l'espèce pisum et/ou phaseolus et/ou vigna et/ou macrotyloma ou provenant de crucifères de l'espèce brassica, qui ne contiennent pas d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2751161B2 (ja) * 1986-10-13 1998-05-18 味の素株式会社 栄養組成物
TNSN02063A1 (en) * 2001-07-07 2005-12-23 Egyptian Natural Oil Co Natoil The medical effect of jojoba oil
FR2827174B1 (fr) * 2001-07-13 2004-08-06 Soc Extraction Principes Actif Utilisation de peptides pour augmenter l'adhesion cellulaire
DE10206353A1 (de) * 2002-02-14 2003-08-28 Cognis Deutschland Gmbh Verwendung von niedermolekularen Proteinhydralysaten
FR2869228B1 (fr) * 2004-04-21 2008-09-05 Vincience Sa Utilisation d'un hydrolysat de proteines de cruciferes en tant qu'agent depigmentant dans ou pour une composition cosmetique et/ou pharmaceutique
FR2925327A1 (fr) * 2007-12-21 2009-06-26 Vincience Sa Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines
FR2925326B1 (fr) * 2007-12-21 2010-02-26 Vincience Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines
FR2925330B1 (fr) * 2007-12-21 2010-04-09 Vincience Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines
FR2925325B1 (fr) * 2007-12-21 2010-02-26 Vincience Utilisation d'un hydrolysat de colza en tant que principe actif activateur de la synthese des aquaporines

Also Published As

Publication number Publication date
FR2944446A1 (fr) 2010-10-22

Similar Documents

Publication Publication Date Title
FR2944526B1 (fr) Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere
IL209499A (en) Human monoclonal antibody against influenza virus a, Pharmaceutical preparations containing it and its use in drug preparation
HUE049580T2 (hu) Hemagglutinint és mátrixfehérjéket tartalmazó, influenza elleni oltóanyagok
DK2346495T4 (da) Farmaceutisk formulering 514
DK2029134T3 (da) Stabiliserede farmaceutiske præparater omfattende fesoterodin
BR112012013148A2 (pt) formulação farmacêutica e uso
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
BRPI0813897A2 (pt) Uso de uma substância, composição cosmética ou dermo-cosmética ou neutracêutica, composição farmacêutica, método de cuidado cosmético, e, seqüência de nucleotídeos.
FR18C1032I2 (fr) Anticorps anti-fgf23 et composition pharmaceutique le comprenant
FR2958157B1 (fr) Composition cosmetique et pharmaceutique comprenant du n-acetyl-glucosamine-6-phosphate
FR2948568B1 (fr) Formulation pharmaceutique
FR2961814B1 (fr) Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant.
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
BRPI1009823A2 (pt) "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."
BRPI1008887A2 (pt) peptídeos de foxm1 e vacinas contendo os mesmo
BRPI1009301A2 (pt) peptídeos neil 3 e vacinas incluindo os mesmos
FR2958159B1 (fr) Compostion cosmetique ou pharmaceutique
FR2949782B1 (fr) Peptide activateur de la transglutaminase et composition cosmetique ou pharmaceutique le contenant.
FR2944445B1 (fr) Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
FR2944446B1 (fr) Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
BR112012021455A2 (pt) formulação farmacêutica ou nutracêutica.
ZA200809269B (en) Liquid pharmaceutical formulation
FR2962040B3 (fr) Composition injectable comprenant un medicament injectable et un gel

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

ST Notification of lapse

Effective date: 20231205